The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126496751 12649675 1 I 2015 20150906 20160812 20160812 PER US-IMPAX LABORATORIES, INC-2015COR00193 IMPAX 34.19 YR M Y 113.00000 KG 20160812 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126496751 12649675 1 PS MIXED AMPHETAMINE SALTS AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 Oral 30 MG, 1X/DAY Y 40444 30 MG TABLET QD
126496751 12649675 2 SS MIXED AMPHETAMINE SALTS AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 Y 40444 TABLET
126496751 12649675 3 SS MIXED AMPHETAMINE SALTS AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 Y 40444 TABLET
126496751 12649675 4 SS DEXTROAMPHETAMINE SULFATE IR DEXTROAMPHETAMINE SULFATE 1 Oral UNK UNK, 1X/DAY Y 0 TABLET QD
126496751 12649675 5 SS METHYLPHENIDATE HYDROCHLORIDE IR METHYLPHENIDATE HYDROCHLORIDE 1 Oral UNK UNK, 1X/DAY Y 0 TABLET QD
126496751 12649675 6 SS METHYLPHENIDATE HYDROCHLORIDE IR METHYLPHENIDATE HYDROCHLORIDE 1 Y 0 TABLET
126496751 12649675 7 SS METHYLPHENIDATE HYDROCHLORIDE IR METHYLPHENIDATE HYDROCHLORIDE 1 Y 0 TABLET
126496751 12649675 8 SS VYVANSE LISDEXAMFETAMINE DIMESYLATE 1 50 MG, UNK Y 0 50 MG
126496751 12649675 9 SS VYVANSE LISDEXAMFETAMINE DIMESYLATE 1 Y 0
126496751 12649675 10 SS VYVANSE LISDEXAMFETAMINE DIMESYLATE 1 Y 0
126496751 12649675 11 C ALEVE NAPROXEN SODIUM 1 0
126496751 12649675 12 C UNSPECIFIED ALLERGY MEDICATION UNSPECIFIED INGREDIENT 1 0
126496751 12649675 13 C PROTEIN SHAKE 2 UNK, AS NEEDED 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126496751 12649675 1 Narcolepsy
126496751 12649675 2 Eating disorder
126496751 12649675 3 Sleep apnoea syndrome
126496751 12649675 5 Narcolepsy
126496751 12649675 6 Eating disorder
126496751 12649675 7 Sleep apnoea syndrome
126496751 12649675 8 Narcolepsy
126496751 12649675 9 Eating disorder
126496751 12649675 10 Sleep apnoea syndrome

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
126496751 12649675 Drug effect decreased
126496751 12649675 Drug ineffective for unapproved indication
126496751 12649675 Fatigue
126496751 12649675 Hyperphagia
126496751 12649675 Hypothyroidism
126496751 12649675 Incorrect dose administered
126496751 12649675 Increased appetite
126496751 12649675 Iron deficiency
126496751 12649675 Product substitution issue
126496751 12649675 Tongue coated
126496751 12649675 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126496751 12649675 1 201503 0
126496751 12649675 4 20150902 201509 0
126496751 12649675 5 201505 0
126496751 12649675 8 2015 201505 0